『Cover Story』 Sondii Artwork Featured in a Nature Sub-journal: From Chip to Clinic – Decoding the Real Performance of CAR-T Cells in the Solid Tumor Microenvironment

《Published: 17 October 2025》

Haijiao Liu, Estela Noguera-Ortega, Xuanqi Dong, Won Dong Lee, Jeehan Chang, Sezin Aday Aydin, Yumei Li, Yonghee Shin, Xinyi Shi, Maria Liousia, Marina C. Martinez, Joshua J. Brotman, Soyeon Kim, Zeyu Chen, Anni Wang, Zirui Ou, Jungwook Paek, Ju Young Park, Aidi Liu, Haonan Hu, Zebin Xiao, Dora Maria Racca, Se-jeong Kim, G. Scott Worthen, …Dan Dongeun Huh



This issue's cover of Nature Biotechnology features "A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors" a study by the research group of Dan Dongeun Huh at the University of Pennsylvania, in collaboration with a multidisciplinary team spanning pulmonary immunology, clinical oncology, and metabolism.

Research Background

Chimeric antigen receptor (CAR)-T cell therapy has achieved revolutionary success in hematological malignancies, but still faces tremendous challenges in the treatment of solid tumors. The core bottleneck lies in our limited understanding of tumor–immune interactions—particularly how CAR-T cells infiltrate, survive, and exert their cytotoxic effects within the complex solid tumor microenvironment (TME)—coupled with a lack of intuitive in vitro models for real-time observation. Traditional two-dimensional cell culture fails to recapitulate the three-dimensional structure and vasculature of tumors, while animal models suffer from interspecies differences and are difficult to image at high resolution in real time. Therefore, there is an urgent need for an in vitro platform that can highly replicate the physiological features of the human tumor microenvironment to accelerate the optimization and translation of CAR-T therapies.

Research Significance

This study developed an innovative vascularized tumor-on-a-chip system that successfully achieves vascularization of human tumor explants and controlled perfusion of immune cells. This system not only enables the simulation, visualization, and in-depth interrogation of CAR-T cell function within the lung adenocarcinoma microenvironment in vitro, but also validates a chemokine-directed CAR-T engineering strategy (in a malignant pleural mesothelioma model) with results highly consistent with those from matching in vivo mouse models. More importantly, through global metabolomics analysis, the study identified potential therapeutically targetable nodes and biomarkers that can be pharmacologically modulated to enhance CAR-T cell efficacy in lung adenocarcinoma. This microphysiological system provides robust in vitro technological support for the development of adoptive cell therapies, with the potential to substantially shorten drug screening cycles and improve clinical success rates.

Research Outlook

Future research should further expand the applicability of this chip platform to cover a broader range of solid tumor types and more complex immune microenvironment components (such as fibroblasts, matrix proteins, etc.). At the same time, multi-omics technologies (e.g., single-cell sequencing, spatial transcriptomics) should be integrated to deeply dissect the mechanisms of immune evasion or exhaustion observed on the chip and to uncover additional key regulatory targets. Furthermore, promoting the standardization and automation of this system to make it a routine tool for drug discovery and personalized medicine will be key to realizing its clinical value. In the long term, this "organ-on-a-chip" technology is expected to replace some animal experiments and provide more reliable human-relevant data to support precision immunotherapy.

Cover Design Process

The cover design revolves around the core theme of "CAR-T cell therapy modeling on a chip," employing "vascularized tumor spheroids + microfluidic chip array" as dual visual anchors. The three suspended spherical structures at the center of the image intuitively represent "human tumor explants," with the red reticular networks wrapping their surfaces symbolizing the "vascular network," and the regularly arranged microwell arrays at the bottom alluding to the physical carrier of the "microfluidic chip." This combination directly echoes the "tumor-on-a-chip" concept in the article title, rendering this abstract bioengineering system into a concrete visual form.

The cover is composed of three suspended spheres representing the human tumor explants used in the study. The interior of each sphere employs a purple-and-black granular texture to simulate real tumor cell clusters and the complex extracellular matrix; the bright red reticular lines covering the surface vividly reproduce the process of tumor angiogenesis. This is the core innovation of the study—reconstructing the tumor's blood supply system in vitro so that immune cells can enter the tumor interior through the vasculature. The tiny light spots scattered around the spheres hint at cellular activity and the dynamic micro-scale responses taking place.

The background features a deep-blue microwell array—a signature structure of microfluidic chips—representing the high-throughput screening and precisely controlled experimental environment. The microwells are connected by fine red lines, which symbolize both the fluidic channels within the chip and the flow and interactions of immune signals or CAR-T cells throughout the system. The conical blue light beams projecting upward from the bottom microwells not only create a sense of spatial depth, but also symbolize the "support" and "empowerment" that chip technology provides to the tumor model, highlighting the driving role of engineering in biological research. This design simultaneously showcases the complexity of biology and the precision of engineering, perfectly capturing the research essence of "simulating the in vivo environment in vitro." The design successfully received recognition from the journal editors and was featured on the cover!